EXOSC4 and pancreatic neoplasm: Consistent with their results, we also showed that EXOSC4 knockdown led to the reduction in the viability of pancreatic and colorectal tumor cells, even though EXOSC4 alteration is associated only with a poor prognosis of pancreatic cancer patients.